Meanwhile, CRISPR-based genetic ablation of LMP7 (gene name PSMB8) in the human pancreatic cancer cell line SW 1990 resulted in complete loss of LMP7 staining with EPR14482(B) (Supplementary Figure S1B). This evidence concerns the gene PSMB8 and pancreatic neoplasm.